TAbic M.B., šnypščiosios tabletės
TAbic M.B., šnypščiosios tabletės
Authorised
- Infectious bursal disease virus, strain M.B., Live
Product identification
Medicine name:
TAbic M.B., šnypščiosios tabletės
Active substance:
- Infectious bursal disease virus, strain M.B., Live
Target species:
-
Chicken
Route of administration:
-
In drinking water use
-
Ocular use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain M.B., Live316.2350% Embryo Infective Dose1.00Dose
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
In drinking water use
- Chicken
-
Meat and offal0day
-
-
Ocular use
- Chicken
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Available in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Abic Polska Sp. z o.o.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/04/1611/001-007
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV1611.pdf
Lithuanian (PDF)
Download Published on: 30/06/2022
How useful was this page?: